Mirdametinib
Mirdametinib, also known by its brand name Gomekli, is an oral, highly selective, and potent small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2). Reference standards of Mirdametinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Mirdametinib
[catalogue_number] => PA 27 06106
[category_ids] => ,70,76,78,82,
[chemical_name] =>
[weight] => 482.19
[form] => C16H14F3IN2O4
[cas] => 391210-10-9
[pslug] => 391210-10-9-mirdametinib-pa2706106
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 27 06106
Molecular Formula : C16H14F3IN2O4
Molecular Weight : 482.19